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Introduction: While some studies show that patients submitted to radical nephrectomy 
have a higher risk of developing chronic kidney disease (CKD), some studies report that 
carefully selected living kidney donors do not present a higher risk for CKD. Here, we 
aim to study predictive factors of CKD after radical nephrectomy.
Materials and Methods: Between January 2006 to January 2010, 107 patients submit-
ted to radical nephrectomy for cortical renal tumors at our institution were enrolled 
in this study. Demographic data were recorded, modified Charlson-Romano Index was 
calculated, and creatinine clearance was estimated using abbreviated Modification of 
Diet in Renal Disease (MDRD) study equation. Pathological characteristics, surgical ac-
cess and surgical complications were also reviewed. The end-point of the current study 
was new onset estimated glomerular filtration rate (eGFR) less than 60 and less than 
45 mL/minute/1.73 m2.
Results: Age, preoperative eGFR, Charlson-Romano Index and hypertension were pre-
dictive factors of renal function loss, when the end-point considered was eGFR lower 
than 60 mL/minute/1.73 m2. Age and preoperative eGFR were predictive factors of 
renal function loss, when the end-point considered was eGFR lower than 45 mL/min-
ute/1.73 m2. Moreover, each year older increased 1.1 times the risk of eGFR lower than 
60 and 45 mL/minute/1.73 m2. After multivariate logistic regression, only age remained 
as an independent predictive factor of eGFR loss.
Conclusion: Age is an independent predictive factor of GFR loss for patients submitted 
to radical nephrectomy for cortical renal tumors.
INTROdUCTION
Surgical treatment of renal cortical tumors is 
changing in the last decade. Best management must 
consider preservation of renal function in order to 
increase global survival rate. Radical nephrectomy 
(RN) was considered the gold standard treatment for 
localized renal cortical tumor (1), however the waste 
of nephrons causes loss of renal function that is be-
ing implicated in the global survival rate decrease. 
Nephron sparing surgery has specific survival rates 
similar to those achieved with RN while preserves 
renal function. Despite the paradigm change, partial 
nephrectomy represents only 30-65% of all surgical 
procedures for renal cortical tumors in tertiary-care 
centers in the United States (2-4). Low volume cen-
ters present an even worse figure and RN remains 
the standard treatment for most cases (5).
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Advances in imaging exams have led to in-
creased detection of incidental, small (< 4cm), lo-
calized renal cortical tumors. But some tumors can-
not be treated by nephron sparing surgery without 
compromising safety and oncological efficacy, due 
to a challenging central localization. Even small 
tumors in the central region may compromise the 
renal fat around the hilum and despite the low tu-
mor volume, the possibility of a T3 should be con-
sidered and therefore RN may still be appropriate in 
this scenario (6). It has been reported that although 
experienced surgeons have similar outcomes with 
radical or partial nephrectomy (7,8), the partial ap-
proach can be technically challenging and associ-
ated with greater risk of complications, especially if 
done laparoscopically (9,10).
Huang et al. showed that patients submitted 
to radical nephrectomy have a higher risk of devel-
oping chronic kidney disease (CKD) than patients 
subjected to partial nephrectomy (11). However, 
carefully selected living kidney donors do not pres-
ent a higher risk for CKD (12). Moreover, it has been 
shown that long-term mortality rate is not signifi-
cantly increased in living kidney donors (13). These 
findings led us to looking for patients and tumors 
features that might influence and could predict 
which patients will evolve to renal function loss.
In this study, we aim to evaluate demo-
graphic data, pathological features, surgical ac-
cess, and postoperative complications as predic-
tors of CKD after radical nephrectomy for cortical 
renal tumors.
MATERIALS ANd METHOdS
Between January 2006 and January 2010, 
180 patients were submitted to RN for cortical re-
nal tumors at our institution. We included only pa-
tients treated after 2006 because nephron sparing 
surgery was already consolidated as the best option 
for small renal tumors at this time. Patients with 
end-stage renal disease, bilateral renal tumors or 
metastases at surgery, and those with less than 12 
months of follow-up or incomplete data were ex-
cluded from our analysis. Only patients with imag-
es of a normal contralateral kidney before surgery 
were selected. Thus, 107 patients were enrolled in 
this retrospective study.
Clinical characteristics, including age at 
surgery, gender, hypertension, cerebrovascular and 
pulmonary disease, and liver dysfunction were re-
corded. Modified Charlson-Romano Index (14,15) 
was calculated as an objective measure of compar-
ing comorbidity among patients. Also, preopera-
tive serum creatinine was recorded and Glomeru-
lar Filtration Rate (GFR) was estimated using the 
abbreviated Modification of Diet in Renal Disease 
(MDRD) study equation (186 x serum creatinine in 
mg/dL-1.154 x age in years-0.0203 x 0.742 if fe-
male). Pathological characteristics, including size 
and pT stage were also reviewed. Surgical access 
(laparoscopic versus open) was analyzed as well as 
Clavien-Dindo classification of surgical complica-
tions (16) used to estimate if postoperative period 
could have influenced the renal function outcome.
The end-point of the current study was new 
onset eGFR less than 60 and less than 45 mL/min-
ute/1.73 m2, which defines chronic kidney disease 
more accurately and has been shown to be associ-
ated with a significantly higher risk of complica-
tions and comorbidity (17-19). Patients had their 
postoperative eGFR assessed 6 months after surgery 
and at the end of the follow-up period. Since the 
main outcome measures were the new onset of GFR 
lower than 60 or 45 mL/minute/1.73 m2 after sur-
gery, patients with pre-existing GFR values lower 
than these two thresholds were not included for 
outcome analysis.
In order to determinate p values, we used 
Mann-Whitney test or Student t test for continu-
ous variables and Chi-square test for categorical 
variables. Because of the small frequency of post-
operative complications, Fisher exact test was used 
for Clavien-Dindo classification. After univariate 
analysis, multivariate logistic regression was done 
to determine the real effect of each hypothesized 
risk factor. All statistical analysis was performed 
with p < 0.05 considered significant.
RESULTS
Mean (range) age at surgery was 58.5 (25 - 
86) years and 62 (57.9%) patients were male. Mean 
(range) Charlson-Romano Index was 1.8 (0 - 9) 
and 43 (40.2%) patients had hypertension. Eighty 
and four (78.5%) were submitted to open radical 
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had eGFR lower than 60 mL/minute/1.73 m2 six 
months after surgery, while 14 patients had eGFR 
lower than 45 mL/minute/1.73 m2 at the same pe-
riod. At the end of the follow-up, 29 patients had 
eGFR lower than 60 mL/minute/1.73 m2, because 
three presented a small improvement in the renal 
function, and 16 patients had eGFR lower than 45 
mL/minute/1.73 m2.
When the end-point considered was eGFR 
lower than 60 mL/minute/1.73 m2, age (p = 0.002), 
Charlson-Romano Index (p = 0.01) and hyperten-
sion (p = 0.04) were significant predictors of renal 
nephrectomy, while 23 (21.5%) to laparoscopic ap-
proach. Demographic data, surgical access (open 
vs. laparoscopic), surgical pathology, and Clavien-
Dindo classification are summarized in Table-1. 
Mean (range) operative time was 108 (70 - 210) 
minutes. Mean (range) estimated blood loss was 
180 (50 - 700) mL. Mean (range) preoperative eGFR 
was 72 (60 - 150) mL/minute/1.73 m2. Mean (range) 
follow-up was 32 (18 - 54) months.
After 6 months and at the end of the fol-
low-up period mean eGFR was 58.2 and 57.6 mL/
minute/1.73 m2, respectively. Thirty-two patients 
Table 1 – demographic data, surgical access, surgical pathology, and Clavien-dindo Classiﬁcation.
Mean (range) age 58.5 (25 - 86) years 
Median age 59 years
Gender 62 (57.9%) male 45 (42.1%) female
Mean (range) Charlson Index 1.8 (0 - 9)
Median Charlson Index 1
Hypertension 43 (40.2%) yes 64 (59.8%) no
Surgical access 84 (78.5%) open 23 (21.5%) laparoscopic
Pathology 97 (90.6%) clear cell carcinoma
 10 (9.4%) chromophobe carcinoma
Pathological stage pT1 37 (34.6%)
pT2 25 (23.4%)
pT3 37 (34.6%)
 pT4 8 (7.5%)
Clavien-Dindo classification 0 100 (93.5%)
1 4 (3.7%)
2 1 (0.9)
3 2 (1.9%)
4 0
5 0
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function loss at six months of follow-up. At the end 
of that period, these factors and preoperative eGFR 
(p = 0.02) were significant predictors of renal func-
tion loss (Table-2). Moreover, for each year older, 
the risk of eGFR lower than 60 mL/minute/1.73 m2 
increased 1.1 times, and for each point acquired 
in the Charlson-Romano Index, the risk of eGFR 
lower than 60 mL/minute/1.73 m2 increased 1.24 
times. However, after multivariate logistic regres-
sion, only age (p = 0.005) remained as an indepen-
dent predict factor of eGFR loss.
When the end-point considered was eGFR 
lower than 45 mL/minute/1.73 m2, age (p = 0.003) 
and preoperative eGFR (p = 0.01) were predictors 
of renal function loss at six months of follow-up. 
Charlson-Romano Index (p = 0.08) appeared to be 
higher in patients with eGFR loss. All these find-
ings persisted until the end of the follow-up period 
(Table-2). Again, for each year older, the risk of 
eGFR lower than 45 mL/minute/1.73 m2 increased 
1.1 times. After multivariate logistic regression, 
age remained (p = 0.001) as an independent pre-
dictor factor of eGFR loss.
Table 2 – Predictive factors of development of chronic kidney disease following radical nephrectomy (univariate analysis).
 eGFR < 60 mL/min/1.73 m2 eGFR < 45 mL/min/1.73 m2
 6 months End 6 months End
Age p = 0.002 p < 0.001 p = 0.003 p = 0.001
Gender p = 0.61 p = 0.07 p = 0.51 p = 0.16
Preoperative eGFR p = 0.23 p = 0.02 P = 0.01   P < 0.001
Charlson-Romano Index p = 0.01 p = 0.01 p = 0.08 p = 0.09
Hypertension p = 0.05 p = 0.04 p = 0.72 p = 0.11
Surgical access p = 0.67 p = 0.41 p = 0.96 p = 1.00
Pathological stage p = 0.17 p = 0.44 p = 0.65 p = 0.41
Clavien-Dindo classification p = 1.00 p = 0.63 p = 0.21 p = 0.32
95% CI    
dISCUSSION
This study presents original and relevant 
data. Multivariate logistic regression shows that 
age is the only predictor related to renal function 
loss after radical nephrectomy (OR: 1.1, 95% CI 
1.04-1.15). Moreover, the risk of eGFR lower than 
60 or 45 mL/minute/1.73 m2 after RN increases 
10% for each year older.
The 3-year probability of absence of new 
onset of GRF lower than 60 mL/min per 1.73 m2 is 
80% and 35% after partial and radical nephrecto-
my, respectively. The corresponding values for GFR 
lower than 45 mL/min per 1.73 m2 are 95% and 
64% (11). However, partial nephrectomy is not al-
ways possible due to large renal tumors, central lo-
calized tumors, or in some cases, when performed 
mainly in small centers, because inexperienced 
surgeons are not used to the procedure. In these 
situations, it is very important for the surgeon to 
predict which patients are potential candidates to 
radical nephrectomy without compromising GFR 
outcome and patient survival. Even in those cases 
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where radical nephrectomy is the only option, it is 
very beneficial to know the risk of new onset of 
CKD to prepare patients and medical care team to 
this unpleasant event.
Outcome data from transplantation studies 
(20-22) have long supported that CKD after total 
nephrectomy is not a major concern in patients 
with two equivalent functioning kidneys and nor-
mal preoperative concentration of serum creati-
nine, since donors submitted to nephrectomy do 
not show decrease of their kidney function, kid-
ney failure needing dialysis, or death. However, 
this is not observed in patients submitted to RN 
for cortical renal tumors. These findings encour-
aged us to look for which factors could influence 
and predict which patients would evolve to renal 
function loss.
Yokoyama et al. (23) retrospectively stud-
ied 416 patients submitted to nephrectomy and 
after univariate and multivariate analysis radical 
nephrectomy was an independent risk factor for 
new onset eGFR less than 60 mL/min per 1.73 m2 
(HR 3.19, 95% CI 1.72 - 6.75) but not for new on-
set eGFR less than 45 mL/min per 1.73 m2. Age at 
surgery and preoperative eGFR were independent 
risk factors for new onset less than 45 mL/min per 
1.73 m2. Barlow et al. (24) presented similar results 
in another retrospectively study with 209 patients 
submitted to nephrectomy and with preopera-
tive eGFR higher than 60 mL/min per 1.73 m2. On 
multivariate analysis, preoperative CKD and pro-
cedure (radical versus partial) were independent 
predictors of new onset renal insufficiency. In this 
study, hypertension was an independent predictor 
of CKD upstage. Suer et al. (25) studied the long-
term impact of hypertension and diabetes mellitus 
on GFR in the long term in 488 patients submitted 
to nephrectomy and noted that hypertension was 
associated with new onset of chronic renal failure 
only in the radical nephrectomy group (HR 1.39, 
95% CI 1.02 - 1.89).
In our study, age, preoperative eGFR, and 
hypertension were related to renal function loss, 
corroborating literature data. Our study presents 
an original contribution that may improve the 
care of patients that suffer from renal tumors and 
are going to be submitted to RN. We found that 
for each year older, the risk of eGFR lower than 60 
or 45 mL/minute/1.73 m2 after RN increases 10%.
In partial nephrectomy, predicting factors 
of lower GFR were well studied in a large cohort 
of 1169 patients by Lane et al. (26). Lower preop-
erative GFR, solitary kidney, older age, tumor size 
and longer ischemic interval were all predicting 
factors of bad renal function outcome. However, 
unfortunately, this paper did not study patient’s 
comorbidities and did not evaluate which of these 
factors could predict CKD in patients that are not 
candidate to partial nephrectomy. Santos Arron-
tes et al. (27) studied the survival rate after ne-
phrectomy for clear cell carcinoma according to 
the Charlson comorbidity index in 192 patients 
submitted to nephrectomy. They reported that tu-
mor stage and comorbidity (Charlson greater than 
two) were prognostic factors after one, five and 
ten years of follow-up. The authors concluded that 
the comorbidity index should be applied in daily 
clinical practice to assess the best therapeutic op-
tion for patients. In our study, the Charlson-Ro-
mano Index was related to renal function loss, and 
for each point acquired in the Charlson-Romano 
Index, the risk of eGFR lower than 60 mL/min-
ute/1.73 m2 increased 1.24 times. It appears that 
Charlson-Romano Index is an important factor 
that should be used in patients that will be sub-
mitted to nephrectomy.
Our study has some limitations. It includes 
a small sample, which may have affected our mul-
tivariate analysis, and as a retrospective study, 
patients were not randomly assigned to open or 
laparoscopic procedure, which means that the 
choice of surgical technique has been biased by 
the surgeon’s preference. However, we may note 
that partial nephrectomy, when technically fea-
sible, must be performed in older patients. In our 
study, as we are a tertiary reference service, we 
have treated complex cases and/or central local-
ized mass, leading to a high prevalence of RN 
and open approach. Another limitation is that 
the median follow-up period of 32 months may 
not have been long enough to draw conclusions 
on long-term postoperative renal function. May-
be in a future publication this doubt can be re-
solved. Large studies with longer follow-up are 
needed to evaluate long-term renal function after 
radical nephrectomy.
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CONCLUSIONS
Age is an independent predicting factor 
of GFR loss for patients submitted to radical ne-
phrectomy for cortical renal tumors. Each year 
old increases 10% the risk of CKD after radical 
nephrectomy. Preoperative eGFR and Charlson-
Romano Index also should be evaluated before 
nephrectomy.
ABBREVIATIONS 
RN - Radical Nephrectomy
CKD - Chronic Kidney Disease
GFR - Glomerular Filtration Rate
MDRD - Modification of Diet in Renal Disease
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EdITORIAL COMMENT
This is an interesting retrospective study 
about possible prediction factors (age, preopera-
tive renal function, Charlson-Romano-Index and 
hypertension) for chronic kidney disease (CKD) 
in 107 patients submitted to radical nephrectomy 
(RN). Exclusion criteria were end stage renal dis-
ease, bilateral renal tumors, metastases at surgery, 
less than 12 months of follow-up and an abnor-
mal contralateral kidney in imaging studies.
The predictive factors of kidney dysfunc-
tion after RN were age, preoperative renal func-
tion, Charlson-Romano-Index and hypertension, 
when the end point considered estimated was glo-
merular filtration rate (eGFR) lower than 60 mL/
min/1.73m2. When the end point considered was 
eGFR lower than 45 mL/min/1.73m2, only age and 
preoperative eGFR remained as predictive factors. 
Age remained as an independent predictor factor 
of eGFR loss after multivariate logistic regression.
An important limitation of this paper is 
the short period of follow-up (18-54 months), as 
the authors mentioned at Discussion. Further-
more, 34.6% of the patients had small renal tu-
mors (pT1), and missing was information on what 
percentage of patients was potentially eligible for 
partial nephrectomy (PN) but underwent RN in-
stead. The under use of PN can easily be found in 
other studies, despite evidence of equivalent on-
cologic outcomes and an increased likelihood of 
developing CKD and cardiovascular comorbidity 
associated with RN (1-3).
Hence, RN should still be discouraged for 
patients with small renal tumors amenable to par-
tial nephrectomy, including the elderly. As stated 
by the paper’s conclusion, age is undoubtedly a 
predictive factor for CKD after RN. Lowrance et al. 
(4) evaluated age and procedure type and found no 
evidence indicating an increased risk of nephron-
sparing surgery complications with advancing age. 
On the other hand, in this group of patients, active 
surveillance can also be used and safely avoid sur-
gery for Stage T1a renal masses (5).
The title is very attractive, but the ques-
tion still remained without a definite answer (“Can 
we predict which patients will evolve to chronic 
kidney disease after nephrectomy for cortical tu-
mors?”). As pointed by the authors, maybe a fu-
ture study with a longer follow-up and also with 
more strict criteria for the indication for RN could 
contribute even more to this issue.
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